Evidence map›Paper›PMID 40462989›Full record

ArticlebioRxiv : the preprint server for biology2025

R2HaPpY: Rapid-robust phosphotyrosine peptide enrichment using HaloTag-Src SH2 pY superbinder.

Alexis Chang, Ricard A Rodriguez-Mias, Matthew D Berg, Sophie Moggridge, Judit Villén

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Alexis ChangDepartment of Genome Sciences, University of Washington, Seattle, USA, 98105.
Ricard A Rodriguez-MiasDepartment of Genome Sciences, University of Washington, Seattle, USA, 98105.ORCID 0000-0001-7960-6387
Matthew D BergDepartment of Genome Sciences, University of Washington, Seattle, USA, 98105.ORCID 0000-0002-7924-9241
Sophie MoggridgeDepartment of Genome Sciences, University of Washington, Seattle, USA, 98105.
Judit VillénDepartment of Genome Sciences, University of Washington, Seattle, USA, 98105.ORCID 0000-0002-1005-1739

Funding

INTERDISCIPLINARY TRAINING IN GENOMIC SCIENCEST32HG000035 · NHGRI · UNIVERSITY OF WASHINGTON · PI Bruce Colston Trapnell · 1995 to 2026
$24.2M
Emergent properties of signaling network degradation that mediate homeostatic failure during agingR01AG056359 · NIA · UNIVERSITY OF WASHINGTON · PI KAEBERLEIN, MATT, VILLEN, JUDIT · 2017 to 2021
$2.9M
Towards a comprehensive roadmap of cellular signaling.R35GM119536 · NIGMS · UNIVERSITY OF WASHINGTON · PI VILLEN, JUDIT · 2016 to 2020
$2.2M
The role of phosphorylation in the cellular organization of the proteomeR35GM152061 · NIGMS · UNIVERSITY OF WASHINGTON · PI Judit Villen · 2024 to 2026
$1.3M
NHGRI NIH HHS T32 HG000035NIA NIH HHS R01 AG056359NIGMS NIH HHS R35 GM119536NIGMS NIH HHS R35 GM152061
6 · The paper itself

Abstract

Phosphotyrosine signaling plays a critical role in many biological processes, from cell proliferation to immune response. Despite its importance, systems-level analysis of phosphotyrosine signaling remains a challenge due to costly enrichment reagents and labor-intensive protocols. We previously established an automated phosphotyrosine enrichment method for preparing 96 samples in parallel. Here, we further optimize this method by fusing an SH2 phosphotyrosine superbinder to the HaloTag protein. This allows simple and cost-effective preparation of enrichment beads directly from bacterial lysate, expediting reagent preparation from days to hours. Additionally, our new reagent binds phosphotyrosine peptides at higher efficiency than other enrichment reagents. Using this reagent, we detect and quantify 1,651 unique phosphotyrosine sites from EGF stimulated HeLa cells using only ~1 mg of input peptides per replicate. These include 878 regulated pY sites, many of which are low abundance and not previously detected or annotated as EGF-responsive. This streamlined and sensitive method facilitates comprehensive, quantitative mapping of tyrosine phosphorylation dynamics, enabling broader integration of phosphotyrosine signaling into multiomic and network-level models across diverse biological systems and disease states.

Indexed as

EGF signalingmass spectrometryphosphoproteomicsphosphotyrosine enrichmentsignaling

Identifiers

PMID40462989
PMCPMC12132214

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.